Lamotrigine Tablets

Description

Lamotrigine Tablets

Lamotrigine Tablets USP / BP / IP (25 mg / 50 mg / 100 mg / 200 mg)

High-Potency Phenyltriazine Anti-Convulsant & Bipolar Mood Stabilizer

Healthy Life Pharma Private Limited, alongside our specialized global export and marketing division Healthy Inc, is an authorized manufacturer, CDMO services provider, and wholesale supplier of advanced neurological, psychiatric, and central nervous system (CNS) therapeutics. We manufacture a comprehensive, internationally validated range of Lamotrigine Tablets within our state-of-the-art, WHO–GMP certified, high-containment psychotropic manufacturing installations.

Serving as a frontline therapeutic anchor for both seizure control and long-term psychiatric mood stabilization, this essential product represents a high-velocity strategic export to neurology networks, psychiatric hospital infrastructures, national health ministry tenders, and international digital B2B pharmaceutical marketplaces across the CIS region, Sub-Saharan Africa, LATAM, and South-East Asia.

Product Overview

This formulation operates as a “Voltage-Gated Channel Stabilizer & Presynaptic Glutamate Brake.” It ensures patient safety and prevents chaotic electrical storms in the brain by halting the excessive, un-gated release of excitatory neurotransmitters that trigger seizures and manic-depressive mood cycling.

• Mechanism 1 (Voltage-Gated Sodium Channel Blockade): Lamotrigine physically attaches to and stabilizes the inactive conformation of voltage-gated sodium channels on neuronal membranes. This selective action slows down structural channel recovery, physically preventing sustained, high-frequency repetitive firing of neurons.

• Mechanism 2 (Excitatory Amino Acid Suppression): By hyperpolarizing the presynaptic neuronal membrane, it chemically suppresses the pathological release of excitatory neurotransmitters—most notably Glutamate and Aspartate. This arrests the over-excitation of post-synaptic receptors in the cerebral cortex and limbic systems.

• Mechanism 3 (Calcium Channel Regulation): Concurrently, it displays inhibitory actions on voltage-gated N- and P/Q/R-type calcium channels, further shielding the central nervous system against hyper-synchronous electrical discharges to stabilize mood and prevent seizure propagation.

Product Composition & Available Strengths

Because Lamotrigine demands highly delicate, low-dose introductory titration to ensure patient dermatological safety, we manufacture the full compendial strength matrix.

Technical & Logistics Specifications

• HS Code: 3004.90.99 (Medicaments acting on the central nervous system / Psychotropics / Antiepileptics)

• CAS Number: 84057-84-1 (Lamotrigine)

• Dosage Form Options: Standard Oral Compressed Tablets, or Water-Soluble Chewable/Dispersible Tablets (preferred for pediatric neurology networks).

• Packaging Configurations: 10 / 14 / 15 / 30 Tablets per Blister Strip packed exclusively in premium high-barrier Alu-Alu (Cold-Form Foil) or light-resistant deep-amber PVC/PVDC strips. Lamotrigine requires absolute isolation from ambient moisture and UV transit; our tropicalized packaging configurations ensure a full 36-month shelf life in hot, humid Zone IVb export environments.

Psychotropic Manufacturing Governance & Quality Control

• Schedule X Isolation & Air-Pressure Barriers: Lamotrigine handles critical central neuro-signaling pathways and operates at low mass thresholds. To satisfy rigid international B2B regulatory audits, our tableting lines run inside Dedicated, Air-Pressure Segregated Cleanroom Suites. Independent, HEPA-filtered HVAC infrastructure physically isolates these blocks to guarantee absolute zero active cross-contamination.

• Multi-Stage Geometric Blending Precision: Because active Lamotrigine constitutes a narrow percentage of the total mass in low-dose 25 mg tablets, we deploy Automated Multi-Stage Geometric Solid Blending Suites, physically ensuring flawless active drug uniformity down to the microgram across millions of compressed units.

• Validated Release and Disintegration Kinetics: Every export production batch physically undergoes strict Automated In-Vitro Dissolution Profiling, chemically validating that our generic oral formulations achieve fast gastric disintegration and immediate absorption curves to match global innovator references (such as Lamictal).

Primary Indications

• Neurology & Epilepsy: Frontline monotherapy and adjunctive treatment of partial seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut Syndrome in adult and pediatric populations.

• Psychiatry: Long-term maintenance and prophylaxis of Bipolar I Disorder, specifically engineered to delay or completely prevent the recurrence of severe depressive episodes.

Usage Instructions

• The Slow Titration Mandate: Take the tablet orally with a full glass of water. It can be taken consistently either with or without food. To prevent life-threatening immunological reactions, the dosing protocol MUST follow a strict, slow dose-escalation schedule over several weeks (e.g., initiating at 25 mg once daily for 14 days before stepping up).

• The Sudden Rash Emergency Protocol: Advise clinical and retail distribution networks that if a patient develops any unexpected skin rash, fever, or swollen lymph nodes during the first 8 weeks of therapy, they must discontinue Lamotrigine immediately and seek emergency clinical evaluation to rule out severe hypersensitivity syndromes.

• The Valuation of Metabolic Interactions: Lamotrigine metabolism is heavily driven by hepatic glucuronidation. If co-administered alongside Valproic Acid, Lamotrigine clearance drops by half, requiring a major reduction in the Lamotrigine dose. Conversely, co-administration with enzyme-inducers like Carbamazepine doubles Lamotrigine clearance, requiring an increased dose matrix. Dosing must always track the concurrent medication map.

Safety Warning: POTENT HORMONE-INDEPENDENT CNS MOOD STABILIZER. For Neurology and Psychiatry Specialist Supervision Only. The Boxed Warning Matrix (Steven-Johnson Syndrome): Lamotrigine can chemically trigger rare but life-threatening dermatological hyper-reactions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The risk is physically multiplied by exceeding the recommended initial starting doses or executing rapid dose escalations. No Abrupt Discontinuation: Never discontinue therapy abruptly for seizure control; sudden cessation can physically trigger severe rebound Status Epilepticus Seizures. Contraindications: Absolute contraindications in individuals presenting with documented severe hypersensitivity to phenyltriazine derivatives.

Controlled Global Supply Chain & CDMO Licensing

Healthy Life Pharma Private Limited and Healthy Inc provide complete, internationally validated Third-Party Contract Manufacturing (CDMO Services) and bulk private-label export supply for the entire Lamotrigine dosage matrix. Operating under strict controlled-substances authority clearances, we handle all mandatory cross-border documentation (Official Ministry of Health Psychotropic Import Permits, Central Bureau of Narcotics – CBN Export Licenses, WHO-GMP Certificate, COPP, COA, and Complete CTD Format Dossier sets) for seamless customs entry and rapid national registration.

Commercial & Bulk Procurement Inquiries:

• Corporate Head Office: Mumbai, Maharashtra, India

• Primary Manufacturing Base: Boisar, Maharashtra, India

• WhatsApp / Direct Regulatory Helpline: +91 7710003340

• Controlled Substances Registry Email: info@healthyinc.co.in